This inventor holds 2 USPTO granted patents. Top assignee: Merck + Co., Inc.. Active years: 1994-1998.
Company Filing History:
Years Active: 1994-1998
Title: The Innovations of Stephen Authur Parent
Introduction
Stephen Authur Parent is an accomplished inventor based in Cranbury, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the development of yeast mutants for identifying immunosuppressants. With a total of 2 patents, his work has had a notable impact on medical research and applications.
Latest Patents
Among his latest patents, one focuses on DNA encoding 1,3 beta-D glucan synthase subunits. Another important patent involves yeast mutants that are useful for identifying active FK-506 type immunosuppressants. This process utilizes Saccharomyces cerevisiae mutants containing specific mutant genes that are resistant to FK-506 but sensitive to rapamycin. These mutants can be employed in diagnostic procedures for identifying FK-506 and FK-506 type immunosuppressants, as well as in screening assays for compounds exhibiting immunosuppressive activity.
Career Highlights
Stephen Authur Parent is currently associated with Merck & Company, Inc., a leading global healthcare company. His work at Merck has allowed him to explore innovative solutions in the field of immunology and biotechnology. His research has contributed to advancements in understanding and identifying immunosuppressive agents.
Collaborations
Throughout his career, Stephen has collaborated with notable colleagues, including Gary L Chrebet and Cameron M Douglas. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Stephen Authur Parent's contributions to biotechnology and immunology through his patents and research at Merck & Company, Inc. highlight his role as a significant inventor in the field. His work continues to influence the development of new diagnostic and therapeutic approaches.